InsiderTrades.com logo
Shane Barton net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Shane Barton Biography and Net Worth

Insider of (BIOA)

Shane is VP, Finance at BioAge. He brings 25 years of experience in finance and accounting, specializing in biotechnology companies, with comprehensive experience establishing robust SEC reporting structures and Sarbanes-Oxley internal control policies to ensure financial integrity and regulatory compliance. Previously, Shane was VP of Finance, Controller, and Chief Accounting Officer at Precision Biosciences; VP of Finance of Vivelix Pharmaceuticals; and VP of Accounting, Controller, and Chief Accounting Officer of Cempra Pharmaceuticals. He began his career as an auditor in public accounting. Shane received a BS in Accounting from Appalachian State University and is a Certified Public Accountant in the state of North Carolina.

What is Shane Barton's net worth?

The estimated net worth of Shane Barton is at least $55.19 thousand as of September 27th, 2024. Barton owns 2,632 shares of (BIOA) stock worth more than $55,193 as of March 11th. This net worth approximation does not reflect any other investments that Barton may own. Learn More about Shane Barton's net worth.

How do I contact Shane Barton?

The corporate mailing address for Barton and other (BIOA) executives is 3850 Annapolis Ln N Ste 180, PLYMOUTH, MN 55447-5476, United States. (BIOA) can also be reached via phone at +1-612-7474423 and via email at [email protected]. Learn More on Shane Barton's contact information.

Has Shane Barton been buying or selling shares of (BIOA)?

Shane Barton has not been actively trading shares of (BIOA) during the past quarter. Most recently, on Friday, September 27th, Shane Barton bought 2,632 shares of (BIOA) stock. The stock was acquired at an average cost of $18.00 per share, with a total value of $47,376.00. Following the completion of the transaction, the insider now directly owns 2,632 shares of the company's stock, valued at $47,376. Learn More on Shane Barton's trading history.

Who are (BIOA)'s active insiders?

(BIOA)'s insider roster includes Shane Barton (Insider), and Vijay Pande (Director). Learn More on (BIOA)'s active insiders.

Shane Barton Insider Trading History at (BIOA)

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/27/2024Buy2,632$18.00$47,376.002,632View SEC Filing Icon  
See Full Table

Shane Barton Buying and Selling Activity at (BIOA)

This chart shows Shane Barton's buying and selling at (BIOA) by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

(BIOA) Company Overview

(BIOA) logo
BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company's technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.
Read More

Today's Range

Now: $20.97
Low: $20.13
High: $21.47

50 Day Range

MA: N/A

2 Week Range

Now: $20.97
Low: $2.88
High: $26.62

Volume

1,232,131 shs

Average Volume

442,120 shs

Market Capitalization

$751.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A